Cellular responses following ex vivo lung exposure to the nerve agent VX - Potential for additional treatment

Elisabeth Wigenstam1, Anders Bucht1, Lina Thors1

  • 1Swedish Defence Research Agency, CBRN Defence and Security, Umeå, Sweden.

PubMed

Insights

Organophosphorus nerve agent VX causes acute lung injury with airway constriction and oxidative stress. These VX-specific lung responses may offer new therapeutic targets during intoxication.

Area of Science:

  • Toxicology
  • Pulmonary Medicine
  • Pharmacology

Background:

  • Organophosphorus nerve agents cause rapid, lethal respiratory symptoms.
  • Lung injury from nerve agents is understudied.
  • Current treatments focus on symptomatic relief via enzyme and receptor targets.

Purpose of the Study:

  • Investigate cellular responses in rat lung tissue after VX nerve agent exposure.
  • Examine acute (40 min) and extended (24 h) phases post-exposure.
  • Identify potential therapeutic targets for VX-induced lung injury.

Main Methods:

  • Used an ex vivo rat precision-cut lung slice model.
  • Electrostimulation induced a cholinergic response.
  • Assessed protein levels, cell viability, and inflammatory/oxidative stress markers.

Main Results:

  • VX exposure caused acute airway contraction and reduced relaxation.
  • Increased heme oxygenase-1 and matrix metalloproteinase-9 observed.
  • Decreased glutathione levels in incubation medium noted in the acute phase.
  • No significant cellular response differences at 24 h post-VX exposure compared to controls.
  • LPS exposure showed time-dependent inflammatory and oxidative changes.

Conclusions:

  • VX exposure induces specific oxidative responses in the lung.
  • Signs of inflammation and extracellular matrix remodeling were observed.
  • These mechanisms represent potential therapeutic targets during acute VX intoxication.

Related Concept Videos